Hollow fiber bioreactor: New development for the study of contrast agent transport into hepatocytes by magnetic resonance imaging

The aim of our study was to develop a magnetic resonance (MR)‐compatible in vitro model containing freshly isolated rat hepatocytes to study the transport of hepatobiliary contrast agents (CA) by MR imaging (MRI). We set up a perfusion system including a perfusion circuit, a heating device, an oxygenator, and a hollow fiber bioreactor (HFB). The role of the porosity and surface of the hollow fiber (HF) as well as the perfusate flow rate applied on the diffusion of CAs and O2 was determined. Hepatocytes were isolated and injected in the extracapillary space of the HFB (4 × 107 cells/mL). The hepatocyte HFB was perfused with an extracellular CA, gadopentetate dimeglumine (Gd‐DTPA), and gadobenate dimeglumine (Gd‐BOPTA), which also enters into hepatocytes. The HFB was imaged in the MR room using a dynamic T1‐weighed sequence. No adsorption of CAs was detected in the perfusion system without hepatocytes. The use of a membrane with a high porosity (0.5 μm) and surface (420 cm2), and a high flow rate perfusion (100 mL/min) resulted in a rapid filling of the HFB with CAs. The cellular viability of hepatocytes in the HFB was greater than 85% and the O2 consumption was maintained over the experimental period. The kinetics of MR signal intensity (SI) clearly showed the different behavior of Gd‐BOPTA that enters into hepatocytes and Gd‐DTPA that remains extracellular. Thus, these results show that our newly developed in vitro model is an interesting tool to investigate the transport kinetics of hepatobiliary CAs by measuring the MR SI over time. © 2004 Wiley Periodicals, Inc.

[1]  J. Forder,et al.  A versatile oxygenator and perfusion system for magnetic resonance studies. , 2010, Biotechnology and bioengineering.

[2]  R. Semelka,et al.  Contrast agents for MR imaging of the liver. , 2005, Radiologic clinics of North America.

[3]  Eliana Gianolio,et al.  Insights into the use of paramagnetic Gd(III) complexes in MR‐molecular imaging investigations , 2002, Journal of magnetic resonance imaging : JMRI.

[4]  F Lazeyras,et al.  FAST sequences optimization for contrast media pharmacokinetic quantification in tissue , 2001, Journal of magnetic resonance imaging : JMRI.

[5]  J. Patzer,et al.  Advances in Bioartificial Liver Assist Devices , 2001, Annals of the New York Academy of Sciences.

[6]  P. Schmalbrock,et al.  T1 measurements in cell cultures: A new tool for characterizing contrast agents at 1.5T , 2001, Journal of magnetic resonance imaging : JMRI.

[7]  S. Bhatia,et al.  Advances in bioartificial liver devices , 2001, Hepatology.

[8]  F Uggeri,et al.  Abc protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. , 2001, Biochemical and biophysical research communications.

[9]  F. Maggioni,et al.  Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals. , 1999, Journal of computer assisted tomography.

[10]  V. Lorusso,et al.  Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance). , 1999, Journal of computer assisted tomography.

[11]  P. Meier,et al.  Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. , 1999, The Journal of pharmacology and experimental therapeutics.

[12]  F Uggeri,et al.  Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. , 1999, Biochemical and biophysical research communications.

[13]  A. Fulcher,et al.  Thoracopancreatic fistula: clinical and imaging findings. , 1999, Journal of computer assisted tomography.

[14]  E. McFarland,et al.  Cartilage formation in a hollow fiber bioreactor studied by proton magnetic resonance microscopy. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[15]  S. Tanada,et al.  Dialysate pressure isobars in a hollow-fiber dialyzer determined from magnetic resonance imaging and numerical simulation of dialysate flow. , 1998, Artificial organs.

[16]  R. Muller,et al.  Dynamic evaluation of the hepatic uptake and clearance of manganese‐based MRI contrast agents: A 31P NMR study on the isolated and perfused rat liver , 1998, Journal of magnetic resonance imaging : JMRI.

[17]  R. Weissleder,et al.  Preclinical assessment of hepatocyte‐targeted MR contrast agents in stable human liver cell cultures , 1998, Journal of magnetic resonance imaging : JMRI.

[18]  T. James,et al.  NMR spectroscopy and MRI investigation of a potential bioartificial liver , 1998, NMR in biomedicine.

[19]  S. Saini,et al.  Liver-specific MR imaging contrast agents. , 1998, Radiologic clinics of North America.

[20]  P. Ros,et al.  Hepatic imaging. An overview. , 1998, Radiologic clinics of North America.

[21]  F. Kreutz,et al.  Production of highly pure monoclonal antibodies without purification using a hollow fiber bioreactor. , 1997, Hybridoma.

[22]  P. Olinga,et al.  Influence of 48 hours of cold storage in University of Wisconsin organ preservation solution on metabolic capacity of rat hepatocytes. , 1997, Journal of hepatology.

[23]  V. Lorusso,et al.  Hepatic transport of gadobenate dimeglumine in TR-rats. , 1996, Academic radiology.

[24]  G. Bačić,et al.  Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn‐DPDP , 1996, Magnetic resonance in medicine.

[25]  R. Weissleder,et al.  Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro , 1995, Investigative radiology.

[26]  D. Parker,et al.  Flow distributions in hollow fiber hemodialyzers using magnetic resonance Fourier velocity imaging. , 1995, ASAIO journal.

[27]  E. Guibert,et al.  Importance of pH in resuspension media on viability of hepatocytes preserved in University of Wisconsin solution. , 1995, Cell transplantation.

[28]  M V Peshwa,et al.  Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. , 1994, Annals of surgery.

[29]  T. Giorgio,et al.  Mass Transfer in a Hollow Fiber Device Used as a Bioartificial Liver , 1993, ASAIO journal.

[30]  J. Fry,et al.  Maintenance of xenobiotic metabolism and toxicity in rat hepatocyte cultures after cell preservation at 4 degrees. , 1993, Biochemical pharmacology.

[31]  T. Giorgio,et al.  Development of a bioartificial liver: Properties and function of a hollow‐fiber module inoculated with liver cells , 1993, Hepatology.

[32]  R. Tompkins,et al.  Oxygen uptake rates in cultured rat hepatocytes. , 1992, Biotechnology and bioengineering.

[33]  B. Pangrle,et al.  Use of Magnetic Resonance Imaging to Analyze the Performance of Hollow‐Fiber Bioreactors , 1992, Annals of the New York Academy of Sciences.

[34]  G. Groothuis,et al.  Drug transport, viability and morphology of isolated rat hepatocytes preserved for 24 hours in University of Wisconsin solution. , 1992, Biochemical pharmacology.

[35]  R. Gillies,et al.  Iteration of hybridoma growth and productivity in hollow fiber bioreactors using 31P NMR , 1991, Magnetic resonance in medicine.

[36]  Yun Wu,et al.  Long term and large-scale cultivation of human hepatoma Hep G2 cells in hollow fiber bioreactor , 1991, Cytotechnology.

[37]  G. Groothuis,et al.  Preservation of isolated rat and human hepatocytes in UW solution. , 1990, Transplantation proceedings.

[38]  D. Rosen,et al.  In vitro variability in fentanyl absorption by different membrane oxygenators. , 1990, Journal of cardiothoracic anesthesia.

[39]  Georges Belfort,et al.  Quantitative Flow Measurements in Bioreactors by Nuclear Magnetic Resonance Imaging , 1990, Bio/Technology.

[40]  M. Gyngell,et al.  The application of steady-state free precession in rapid 2DFT NMR imaging: FAST and CE-FAST sequences. , 1988, Magnetic resonance imaging.

[41]  P. C. Chau,et al.  Operation and pressure distribution of immobilized cell hollow fiber bioreactors , 1986, Biotechnology and bioengineering.

[42]  T. Mizutani Adsorption of some antibiotics and other drugs on silicone‐coated glass surfaces , 1982, The Journal of pharmacy and pharmacology.

[43]  J. Skyler,et al.  Secretion of Human Prolactin In Vitro 1 , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[44]  M. Williams,et al.  A simple and inexpensive membrane "lung" for small organ perfusion. , 1974, Journal of lipid research.

[45]  P. Gullino,et al.  Cell Culture on Artificial Capillaries: An Approach to Tissue Growth in vitro , 1972, Science.

[46]  O. Greengard,et al.  CYTOMORPHOMETRY OF DEVELOPING RAT LIVER AND ITS APPLICATION TO ENZYMIC DIFFERENTIATION , 1972, The Journal of cell biology.

[47]  Hans Rudolf Gnägi,et al.  CORRELATED MORPHOMETRIC AND BIOCHEMICAL STUDIES ON THE LIVER CELL , 1969, The Journal of cell biology.

[48]  H. Davis,et al.  Studies with implantable artificial capillary units containing rat islets on diabetic dogs , 2004, Diabetologia.

[49]  C J Mullon,et al.  Oxygen delivery to and use by primary porcine hepatocytes in the HepatAssist 2000 system for extracorporeal treatment of patients in end-stage liver failure. , 1998, Advances in experimental medicine and biology.

[50]  C. Baudelet,et al.  The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine. , 1996, Magnetic resonance imaging.

[51]  L. Trudel,et al.  Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production. , 1996, Journal of immunological methods.

[52]  D. Sasse,et al.  Liver architecture. , 1992, Enzyme.

[53]  R. Wahl,et al.  Hepatic imaging. , 1989, Seminars in liver disease.

[54]  P. Seglen Preparation of isolated rat liver cells. , 1976, Methods in cell biology.